Osaic Holdings’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.65M | Sell |
245,465
-17,243
| -7% | -$116K | ﹤0.01% | 1814 |
|
|
2025
Q1 | $1.39M | Buy |
262,708
+20,518
| +8% | +$109K | ﹤0.01% | 1954 |
|
|
2024
Q4 | $1.64M | Sell |
242,190
-39,277
| -14% | -$266K | ﹤0.01% | 1816 |
|
|
2024
Q3 | $1.85M | Buy |
281,467
+61,519
| +28% | +$405K | ﹤0.01% | 1750 |
|
|
2024
Q2 | $1.65M | Buy |
219,948
+122,416
| +126% | +$918K | ﹤0.01% | 1772 |
|
|
2024
Q1 | $972K | Buy |
97,532
+37,426
| +62% | +$373K | ﹤0.01% | 2352 |
|
|
2023
Q4 | $593K | Buy |
60,106
+53,014
| +748% | +$523K | ﹤0.01% | 3011 |
|
|
2023
Q3 | $54.2K | Buy |
7,092
+3,889
| +121% | +$29.7K | ﹤0.01% | 4941 |
|
|
2023
Q2 | $23.9K | Buy |
3,203
+129
| +4% | +$964 | ﹤0.01% | 5433 |
|
|
2023
Q1 | $20.5K | Sell |
3,074
-910
| -23% | -$6.07K | ﹤0.01% | 5540 |
|
|
2022
Q4 | $30K | Buy |
3,984
+599
| +18% | +$4.51K | ﹤0.01% | 5282 |
|
|
2022
Q3 | $36K | Buy |
3,385
+645
| +24% | +$6.86K | ﹤0.01% | 5146 |
|
|
2022
Q2 | $22K | Sell |
2,740
-1,068
| -28% | -$8.58K | ﹤0.01% | 5542 |
|
|
2022
Q1 | $27K | Buy |
3,808
+633
| +20% | +$4.49K | ﹤0.01% | 5479 |
|
|
2021
Q4 | $54K | Buy |
3,175
+780
| +33% | +$13.3K | ﹤0.01% | 5082 |
|
|
2021
Q3 | $54K | Buy |
2,395
+505
| +27% | +$11.4K | ﹤0.01% | 5041 |
|
|
2021
Q2 | $69K | Buy |
+1,890
| New | +$69K | ﹤0.01% | 4792 |
|